Arthritis Research & Therapy

Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 000 patients from Pharmachild and national registries

Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: Data from a multicenter, prospective national cohort study in Japan

Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus

Adult-onset Still's disease biological treatment strategy may depend on the phenotypic dichotomy

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus

Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations

Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF IRAK 1 and NALP3 inflammasome

Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database

A comparative clinical study of PF-0641 a candidate adalimumab biosimilar, and adalimumab reference product (Humira (R)) in the treatment of active rheumatoid arthritis